Cargando…
Psychiatric Aspects of Chloroquine and Hydroxychloroquine Treatment in the Wake of Coronavirus Disease-2019: Psychopharmacological Interactions and Neuropsychiatric Sequelae
BACKGROUND: Chloroquine and hydroxychloroquine are among several experimental treatments being investigated in the urgent response to the coronavirus disease-2019. With increased use of these medications, physicians need to become knowledgeable of these drugs' neuropsychiatric side effects and...
Autores principales: | Hamm, Brandon S., Rosenthal, Lisa J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Consultation-Liaison Psychiatry. Published by Elsevier Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7341047/ https://www.ncbi.nlm.nih.gov/pubmed/32800347 http://dx.doi.org/10.1016/j.psym.2020.06.022 |
Ejemplares similares
-
Hydroxychloroquine and chloroquine for COVID-19: psychiatric aspects of
patient safety considerations
por: Biswas, Partha Sarathi, et al.
Publicado: (2020) -
Aminoquinolines against coronavirus disease 2019 (COVID-19): chloroquine or hydroxychloroquine
por: Sahraei, Zahra, et al.
Publicado: (2020) -
Neuropsychiatric aspects of concussion: acute and chronic sequelae
por: Rao, Vani, et al.
Publicado: (2017) -
Myth surrounding the FDA disapproval of hydroxychloroquine sulfate and chloroquine phosphate as drugs for coronavirus disease 2019
por: Egbuna, Chukwuebuka, et al.
Publicado: (2022) -
Pharmacology of Chloroquine and Hydroxychloroquine
por: Browning, David J.
Publicado: (2014)